查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1966669

基因組學實驗室自動化市場分析及預測（至2035年）：按類型、產品類型、服務、技術、組件、應用、最終用戶、流程、設備和解決方案分類

Lab Automation in Genomics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Process, Device, Solutions
出版日期: | 出版商: Global Insight Services | 英文 353 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

基因組學實驗室自動化市場預計將從2024年的24.4億美元成長到2034年的109億美元，複合年成長率約為16.1%。該市場涵蓋了透過自動化系統簡化基因組研究的技術，提高了DNA定序、PCR和樣本製備的準確性和通量。這些創新減少了人為錯誤和營運成本，同時加快了發現的速度。在機器人和人工智慧技術進步的推動下，該市場在個人化醫療和生物技術領域至關重要，滿足了基因組研究對效率和擴充性日益成長的需求。

受高通量定序和精準醫療需求不斷成長的推動，基因組學實驗室自動化市場正經歷強勁成長。其中，自動化系統細分市場成長最快，這主要得益於先進機器人技術和人工智慧平台的整合應用。這些系統顯著提升了基因組學工作流程的效率和準確性。耗材細分市場（包括試劑和檢測試劑盒）成長率位居第二，這主要得益於基因組學實驗中對可靠、高品質材料的持續需求。

市場區隔
類型 自動化液體處理系統、自動化微孔板處理系統、機器人系統、自動化儲存系統、自動化樣品製備系統
產品 試劑、耗材、設備、軟體
服務 安裝和整合服務、維護和支援服務、諮詢服務
科技 次世代定序、聚合酵素鏈鎖反應、微陣列
成分 硬體和軟體
應用 臨床診斷、藥物發現、刑事鑑定、研發
最終用戶 製藥和生物技術公司、醫院和診斷檢查室、學術研究機構
過程 樣品製備、樣品製備、定序與數據分析
裝置 自動化工作站、自動化移液系統、自動化核酸萃取系統
解決方案 整合解決方案、獨立解決方案

液體處理系統因其在樣本處理方面的精確性和速度而備受關注，成為基因組學實驗室不可或缺的一部分。同時，包括數據分析和管理工具在內的軟體解決方案領域也已成為一個重要的成長點。這源自於基因組數據的日益複雜化以及對高階分析的需求。自動化技術的整合正在為創新應用鋪平道路，並推動基因組學領域的進一步發展。

基因組學實驗室自動化市場呈現動態的市場格局，市場佔有率分佈、定價策略和創新產品推出均呈現變化。主要企業正利用技術進步來提升產品性能，並推動產業競爭。對基因組學應用自動化效率和準確性的追求，是推動該領域發展的關鍵因素。價格競爭持續不斷，體現了提高通量和準確性的價值提案。頻繁的新產品發布，透過展示滿足不斷變化的研究需求的最尖端科技，維持著強大的解決方案儲備。

競爭基準分析顯示，市場集中度較高，由少數主要企業主導，但同時也湧現一些提供利基解決方案的小型公司。監管的影響，尤其是在北美和歐洲，對於確保合規性和安全標準以及塑造市場動態至關重要。這些法規往往會刺激創新，因為企業都在努力滿足嚴格的要求。對個人化醫療和基因組研究日益成長的需求進一步推動了市場發展。人工智慧和機器學習的融合正在提升數據分析能力，儘管面臨高昂的初始成本和對專業人才的需求等挑戰，但仍蘊藏著巨大的成長機會。

主要趨勢和促進因素：

基因組學實驗室自動化市場正經歷強勁成長，這主要得益於技術進步和對高通量定序日益成長的需求。關鍵趨勢包括將人工智慧 (AI) 和機器學習技術應用於資料分析和解讀能力的提升。自動化技術能夠簡化工作流程、減少人為錯誤並提高基因組研究的可重複性。個人化醫療的興起需要快速、精準的基因組分析，而定序技術成本的下降推動了基因組檢測的廣泛應用，進一步刺激了這項需求。此外，新冠疫情加速了自動化解決方案的普及，以滿足大規模檢測和監測的迫切需求。新興市場醫療基礎設施的不斷完善蘊藏著許多機會。能夠提供擴充性、具成本效益自動化解決方案的公司將佔據有利地位，把握這項成長機會。隨著相關人員尋求改善患者預後並簡化監測流程，對精準醫療和基因研究的日益重視預計將持續推動市場擴張。

美國關稅的影響：

全球關稅和地緣政治緊張局勢正對基因組學實驗室自動化市場產生重大影響，尤其是在東亞地區。作為基因組學技術的領導者，日本和韓國正透過加強國內創新和建構區域合作來應對關稅上漲。面對出口限制，中國正加速推動基因體學自動化技術的自給自足。台灣作為重要的半導體製造中心，雖然仍易受地緣政治波動的影響，但仍持續為實驗室自動化系統提供關鍵組件。由於技術進步和對精準醫療需求的不斷成長，全球市場呈現穩健成長態勢。假設供應鏈保持韌​​性且地緣政治穩定，預計到2035年，該市場將顯著擴張。同時，中東衝突可能擾亂全球供應鏈並推高能源價格，進而對營運成本產生潛在影響。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 自動化液體處理系統
    • 自動餐盤處理機
    • 機器人系統
    • 自動化儲存系統
    • 自動化樣品製備
  • 市場規模及預測：依產品分類
    • 試劑和耗材
    • 裝置
    • 軟體
  • 市場規模及預測：依服務分類
    • 安裝和整合服務
    • 維護和支援服務
    • 諮詢服務
  • 市場規模及預測：依技術分類
    • 次世代定序
    • 聚合酵素鏈鎖反應
    • 微陣列
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
  • 市場規模及預測：依應用領域分類
    • 臨床診斷
    • 藥物發現
    • 法醫檢驗
    • 研究與開發
  • 市場規模及預測：依最終用戶分類
    • 製藥和生物技術公司
    • 醫院和診斷檢查室
    • 學術研究機構
  • 市場規模及預測：依製程分類
    • 樣品製備
    • 樣品製備
    • 定序
    • 數據分析
  • 市場規模及預測：依設備分類
    • 自動化工作站
    • 自動化移液系統
    • 自動化核酸萃取系統
  • 市場規模及預測：按解決方案分類
    • 整合解決方案
    • 獨立解決方案

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Tecan Group
  • Hamilton Company
  • Qiagen
  • Perkin Elmer
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Beckman Coulter
  • Eppendorf
  • Illumina
  • Roche Diagnostics
  • Fluidigm
  • Becton Dickinson
  • Analytik Jena
  • Brooks Automation
  • Hudson Robotics
  • Aurora Biomed
  • High Res Biosolutions
  • Labcyte
  • Zymo Research

第9章：關於我們

簡介目錄
Product Code: GIS25311

Lab Automation in Genomics Market is anticipated to expand from $2.44 billion in 2024 to $10.9 billion by 2034, growing at a CAGR of approximately 16.1%. The Lab Automation in Genomics Market encompasses technologies that streamline genomic research through automated systems, enhancing precision and throughput in DNA sequencing, PCR, and sample preparation. These innovations reduce human error and operational costs while accelerating discovery timelines. Driven by advancements in robotics and AI, this market is pivotal in personalized medicine and biotechnology, meeting increasing demands for efficiency and scalability in genomic studies.

The Lab Automation in Genomics Market is experiencing robust growth, fueled by the rising need for high-throughput sequencing and precision medicine. Within this market, the automation systems segment is the top performer, driven by the integration of advanced robotics and AI-driven platforms. These systems enhance efficiency and accuracy in genomic workflows. The consumables segment, including reagents and assay kits, follows as the second highest performer. This is due to the continuous demand for reliable and high-quality materials in genomic experiments.

Market Segmentation
TypeAutomated Liquid Handlers, Automated Plate Handlers, Robotic Systems, Automated Storage Systems, Automated Sample Preparation
ProductReagents and Consumables, Instruments, Software
ServicesInstallation and Integration Services, Maintenance and Support Services, Consulting Services
TechnologyNext-Generation Sequencing, Polymerase Chain Reaction, Microarray
ComponentHardware, Software
ApplicationClinical Diagnostics, Drug Discovery, Forensic Testing, Research and Development
End UserPharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Academic and Research Institutes
ProcessSample Preparation, Library Preparation, Sequencing, Data Analysis
DeviceAutomated Workstations, Automated Pipetting Systems, Automated Nucleic Acid Extraction Systems
SolutionsIntegrated Solutions, Standalone Solutions

Liquid handling systems are gaining significant traction, offering precision and speed in sample processing, making them indispensable in genomics labs. Meanwhile, the software solutions sub-segment, which includes data analysis and management tools, is also emerging as a critical area of growth. This is attributable to the increasing complexity of genomic data and the need for sophisticated analysis. The convergence of automation technologies is paving the way for innovative applications, driving further advancements in the genomics landscape.

The Lab Automation in Genomics Market is characterized by a dynamic landscape of market share distribution, pricing strategies, and innovative product launches. Key players are leveraging technological advancements to enhance their product offerings, driving competitiveness within the industry. The pursuit of automation efficiency and precision in genomic applications is propelling the sector forward. Pricing remains competitive, reflecting the value proposition of enhanced throughput and accuracy. New product launches are frequent, showcasing cutting-edge technologies that cater to evolving research needs, thus maintaining a robust pipeline of solutions.

Competition benchmarking reveals a concentrated market with a few dominant players, yet smaller firms are emerging with niche solutions. Regulatory influences, particularly in North America and Europe, are pivotal in shaping market dynamics, ensuring compliance and safety standards. These regulations often drive innovation, as companies strive to meet stringent requirements. The market is further bolstered by increasing demand for personalized medicine and genomic research. The integration of AI and machine learning is enhancing data analysis capabilities, offering significant growth opportunities despite challenges like high initial costs and the need for skilled personnel.

Geographical Overview:

The Lab Automation in Genomics Market is witnessing notable growth across various regions, each presenting unique opportunities. North America remains a dominant force, driven by advanced healthcare infrastructure and significant investments in genomics research. The region's focus on personalized medicine further propels the demand for lab automation. Europe follows closely, with strong emphasis on precision medicine and government support for genomics initiatives. The region's robust regulatory framework and investment in healthcare innovation enhance market growth. In the Asia Pacific, the market is expanding rapidly, supported by technological advancements and increasing healthcare expenditure. Countries like China and India are emerging as key players, investing heavily in genomics research and automation technologies. Latin America and the Middle East & Africa are burgeoning markets with untapped potential. In Latin America, growing awareness and investments in healthcare infrastructure drive market expansion, while the Middle East & Africa focus on modernizing healthcare systems and embracing genomics advancements.

Key Trends and Drivers:

The Lab Automation in Genomics Market is experiencing robust growth, driven by technological advancements and increasing demand for high-throughput sequencing. Key trends include the integration of artificial intelligence and machine learning, which enhance data analysis and interpretation capabilities. Automation technologies are streamlining workflows, reducing human error, and improving reproducibility in genomic research. The rise of personalized medicine is a significant driver, as it necessitates rapid and accurate genomic analyses. This demand is further fueled by the decreasing costs of sequencing technologies, making genomic testing more accessible. Additionally, the COVID-19 pandemic has accelerated the adoption of automated solutions to meet the urgent need for large-scale testing and research. Opportunities abound in emerging markets where healthcare infrastructure is expanding. Companies that offer scalable and cost-effective automation solutions are well-positioned to capitalize on this growth. The increasing focus on precision medicine and genetic research is expected to sustain market expansion, as stakeholders seek to enhance patient outcomes and streamline research processes.

US Tariff Impact:

Global tariffs and geopolitical tensions are exerting considerable influence on the Lab Automation in Genomics Market, particularly in East Asia. Japan and South Korea, both leaders in genomics technology, are navigating increased tariffs by bolstering domestic innovation and forging regional alliances. China, facing export controls, is accelerating its push towards self-sufficiency in genomics automation technologies. Taiwan, a pivotal player in semiconductor manufacturing, remains vulnerable to geopolitical volatility, yet continues to supply critical components for lab automation systems. The global market is witnessing robust growth driven by technological advancements and rising demand for precision medicine. By 2035, the market is poised for significant expansion, contingent on resilient supply chains and geopolitical stability. Meanwhile, Middle East conflicts could disrupt global supply chains and elevate energy prices, impacting operational costs.

Key Players:

Tecan Group, Hamilton Company, Qiagen, Perkin Elmer, Agilent Technologies, Bio- Rad Laboratories, Thermo Fisher Scientific, Beckman Coulter, Eppendorf, Illumina, Roche Diagnostics, Fluidigm, Becton Dickinson, Analytik Jena, Brooks Automation, Hudson Robotics, Aurora Biomed, High Res Biosolutions, Labcyte, Zymo Research

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Device
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Automated Liquid Handlers
    • 4.1.2 Automated Plate Handlers
    • 4.1.3 Robotic Systems
    • 4.1.4 Automated Storage Systems
    • 4.1.5 Automated Sample Preparation
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Reagents and Consumables
    • 4.2.2 Instruments
    • 4.2.3 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Installation and Integration Services
    • 4.3.2 Maintenance and Support Services
    • 4.3.3 Consulting Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Next-Generation Sequencing
    • 4.4.2 Polymerase Chain Reaction
    • 4.4.3 Microarray
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Clinical Diagnostics
    • 4.6.2 Drug Discovery
    • 4.6.3 Forensic Testing
    • 4.6.4 Research and Development
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Pharmaceutical and Biotechnology Companies
    • 4.7.2 Hospitals and Diagnostic Laboratories
    • 4.7.3 Academic and Research Institutes
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Sample Preparation
    • 4.8.2 Library Preparation
    • 4.8.3 Sequencing
    • 4.8.4 Data Analysis
  • 4.9 Market Size & Forecast by Device (2020-2035)
    • 4.9.1 Automated Workstations
    • 4.9.2 Automated Pipetting Systems
    • 4.9.3 Automated Nucleic Acid Extraction Systems
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Integrated Solutions
    • 4.10.2 Standalone Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Process
      • 5.2.1.9 Device
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Process
      • 5.2.2.9 Device
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Process
      • 5.2.3.9 Device
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Process
      • 5.3.1.9 Device
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Process
      • 5.3.2.9 Device
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Process
      • 5.3.3.9 Device
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Process
      • 5.4.1.9 Device
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Process
      • 5.4.2.9 Device
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Process
      • 5.4.3.9 Device
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Process
      • 5.4.4.9 Device
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Process
      • 5.4.5.9 Device
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Process
      • 5.4.6.9 Device
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Process
      • 5.4.7.9 Device
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Process
      • 5.5.1.9 Device
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Process
      • 5.5.2.9 Device
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Process
      • 5.5.3.9 Device
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Process
      • 5.5.4.9 Device
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Process
      • 5.5.5.9 Device
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Process
      • 5.5.6.9 Device
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Process
      • 5.6.1.9 Device
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Process
      • 5.6.2.9 Device
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Process
      • 5.6.3.9 Device
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Process
      • 5.6.4.9 Device
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Process
      • 5.6.5.9 Device
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Tecan Group
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Hamilton Company
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Qiagen
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Perkin Elmer
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Agilent Technologies
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Bio- Rad Laboratories
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Thermo Fisher Scientific
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Beckman Coulter
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Eppendorf
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Illumina
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Roche Diagnostics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Fluidigm
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Becton Dickinson
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Analytik Jena
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Brooks Automation
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Hudson Robotics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Aurora Biomed
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 High Res Biosolutions
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Labcyte
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Zymo Research
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us